Skip to main content
. 2012 Feb 10;7(2):e30755. doi: 10.1371/journal.pone.0030755

Figure 2. Verification of population spike recovery in the presence of kinin-B1 receptor agonists and antagonists.

Figure 2

Synaptically elicited PSs were recorded in the stratum pyramidale region in the absence of NMDA. Control slices were treated only with ACSF and compared with slices treated with 100 nM or 1 µM concentrations of the B1BKR receptor antagonist Lys-des-Arg9-Leu8-BK or agonist Lys-des-Arg9-BK. PSs were measured before and after the application of peptides. Data are presented as mean values ± S.D. (n = 28).